Stock Earnings

Question 1

What are Sellas Life Sciences Group Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Sellas Life Sciences Group Inc has a total asset of $19, Net loss of $-31

Question 2

What are the key financial ratios for SLS?

Accepted Answer

Sellas Life Sciences Group Inc's Current ratio is 2.11, has a Net margin is 0, sales per share of $0.

Question 3

How is Sellas Life Sciences Group Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Sellas Life Sciences Group Inc data is not available.

Question 4

Is Sellas Life Sciences Group Inc profitable?

Accepted Answer

no, according to the latest financial statements, Sellas Life Sciences Group Inc has a net loss of $-31

Question 5

Does Sellas Life Sciences Group Inc have any liabilities?

Accepted Answer

yes, Sellas Life Sciences Group Inc has liability of 9

Question 6

How many outstanding shares for Sellas Life Sciences Group Inc?

Accepted Answer

Sellas Life Sciences Group Inc has a total outstanding shares of 73.97

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	1	7	1
Revenue Growth (YoY)	--	--	-100%	-86%	600%	--
Cost of Revenue	--	--	0	0	0	--
Gross Profit	--	--	0	0	7	--
Selling, General & Admin	11	12	13	12	11	9
Research & Development	15	--	24	20	15	9
Operating Expenses	26	32	37	32	26	18
Other Non Operating Income (Expenses)	--	0	0	0	4	0
Pretax Income	-25	-31	-37	-41	-20	-16
Income Tax Expense	--	--	0	0	0	0
Net Income	-25	-31	-37	-41	-20	-16
Net Income Growth	-22%	-16%	-10%	105%	25%	-41%
Shares Outstanding (Diluted)	108.39	61	27.77	19.4	15.48	7.98
Shares Change (YoY)	59%	120%	43%	25%	94%	212%
EPS (Diluted)	-0.23	-0.5	-1.34	-2.13	-1.34	-2.11
EPS Growth	-51%	-63%	-37%	59%	-36%	-81%
Free Cash Flow	-30	-35	-36	-28	-26	-10
Free Cash Flow Per Share	-0.27	-0.57	-1.29	-1.44	-1.67	-1.25
Gross Margin	--	--	0%	0%	100%	--
Operating Margin	0%	0%	0%	-3,100%	-271.42%	-1,600%
Profit Margin	0%	0%	0%	-4,100%	-285.71%	-1,600%
Free Cash Flow Margin	0%	0%	0%	-2,800%	-371.42%	-1,000%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	-26	-32	-37	-31	-19	-16
EBIT Margin	0%	0%	0%	-3,100%	-271.42%	-1,600%
Effective Tax Rate	--	--	0%	0%	0%	0%

Sellas Life Sciences Group Inc (SLS) Price